Participate in a survey on Australia’s Vaccine Commercialisation Landscape
26 April 2024
Biointelect's Jennifer Herz and Dr Patricia Vietheer are leading a retrospective analysis of Australian vaccine development to identify key trends, challenges, and opportunities.
They are calling for valued members of the Australian vaccine development community, to share insights and lived experiences in a survey exploring the Australian vaccine landscape over the past 20 years.
This short survey aims to collect data on prophylactic vaccine candidates targeting infectious diseases developed by Australian institutions and companies since 2003.
The survey aims to capture the challenges and successes encountered during the vaccine research, development and commercialisation process.
All responses will be anonymised - the data is being published for research purposes only, and will not be sold for commercial purposes.
Please submit responses by Friday May 10 2024. If you have any questions or feedback, please reach out to epronker@biointelect.com.
Please consider forwarding this survey to your network to help Biointelect gather a diverse range of perspectives.
Thank you in advance for your participation and support.They are hoping